| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chemokines | 60 | 2021 | 954 | 8.500 |
Why?
|
| Receptors, CXCR3 | 58 | 2023 | 238 | 5.920 |
Why?
|
| Receptors, Chemokine | 54 | 2019 | 652 | 5.620 |
Why?
|
| Chemokines, CXC | 64 | 2012 | 416 | 5.220 |
Why?
|
| Chemokine CXCL10 | 77 | 2023 | 309 | 4.900 |
Why?
|
| Chemotaxis, Leukocyte | 37 | 2017 | 661 | 4.510 |
Why?
|
| Cell Movement | 63 | 2021 | 5201 | 3.300 |
Why?
|
| Receptors, Leukotriene B4 | 23 | 2017 | 92 | 3.180 |
Why?
|
| Neutrophils | 31 | 2024 | 3763 | 2.900 |
Why?
|
| Chemokines, CC | 34 | 2013 | 283 | 2.750 |
Why?
|
| Th2 Cells | 19 | 2020 | 1056 | 2.650 |
Why?
|
| Leukotriene B4 | 21 | 2018 | 280 | 2.550 |
Why?
|
| T-Lymphocytes | 50 | 2023 | 10175 | 2.470 |
Why?
|
| T-Lymphocyte Subsets | 20 | 2020 | 1797 | 2.300 |
Why?
|
| CD8-Positive T-Lymphocytes | 39 | 2021 | 4570 | 2.010 |
Why?
|
| Hypersensitivity | 16 | 2023 | 1167 | 1.980 |
Why?
|
| Th1 Cells | 13 | 2021 | 1027 | 1.780 |
Why?
|
| Immunity | 8 | 2021 | 994 | 1.760 |
Why?
|
| Immunologic Memory | 15 | 2020 | 1355 | 1.760 |
Why?
|
| Inflammation | 49 | 2023 | 10759 | 1.720 |
Why?
|
| Receptor, Anaphylatoxin C5a | 3 | 2019 | 87 | 1.640 |
Why?
|
| Monocytes | 23 | 2021 | 2565 | 1.640 |
Why?
|
| Chemokine CXCL9 | 29 | 2020 | 135 | 1.620 |
Why?
|
| CD4-Positive T-Lymphocytes | 31 | 2024 | 4365 | 1.610 |
Why?
|
| Arthritis, Experimental | 7 | 2016 | 291 | 1.610 |
Why?
|
| Receptors, CCR7 | 7 | 2018 | 107 | 1.590 |
Why?
|
| Neutrophil Infiltration | 7 | 2020 | 390 | 1.560 |
Why?
|
| Lymph Nodes | 20 | 2021 | 3461 | 1.480 |
Why?
|
| Asthma | 31 | 2023 | 6234 | 1.470 |
Why?
|
| Mice | 204 | 2024 | 81368 | 1.470 |
Why?
|
| Animals | 251 | 2024 | 168202 | 1.450 |
Why?
|
| Dendritic Cells | 21 | 2021 | 2722 | 1.420 |
Why?
|
| Eosinophils | 26 | 2013 | 953 | 1.420 |
Why?
|
| Interferon-gamma | 46 | 2023 | 3145 | 1.400 |
Why?
|
| Receptors, CCR8 | 3 | 2018 | 28 | 1.400 |
Why?
|
| Allergens | 18 | 2023 | 1429 | 1.390 |
Why?
|
| Monocyte Chemoattractant Proteins | 13 | 2004 | 47 | 1.370 |
Why?
|
| Mice, Knockout | 86 | 2023 | 14388 | 1.360 |
Why?
|
| Complement C5a | 3 | 2019 | 100 | 1.340 |
Why?
|
| Mice, Inbred C57BL | 100 | 2023 | 22117 | 1.310 |
Why?
|
| Cytokines | 62 | 2020 | 7373 | 1.290 |
Why?
|
| Immunomodulation | 4 | 2022 | 548 | 1.270 |
Why?
|
| Receptors, CCR5 | 17 | 2016 | 486 | 1.230 |
Why?
|
| Receptors, CCR4 | 6 | 2016 | 77 | 1.220 |
Why?
|
| Chemokine CCL2 | 11 | 2019 | 602 | 1.220 |
Why?
|
| Arthritis | 4 | 2019 | 680 | 1.180 |
Why?
|
| Lung | 32 | 2020 | 9999 | 1.160 |
Why?
|
| Immunity, Innate | 21 | 2023 | 3045 | 1.150 |
Why?
|
| Disease Models, Animal | 51 | 2024 | 18220 | 1.130 |
Why?
|
| Lymphoid Tissue | 9 | 2019 | 445 | 1.110 |
Why?
|
| Malaria, Cerebral | 4 | 2019 | 136 | 1.090 |
Why?
|
| T-Lymphocytes, Regulatory | 11 | 2023 | 3077 | 1.070 |
Why?
|
| Chemotaxis | 16 | 2013 | 598 | 1.050 |
Why?
|
| Transendothelial and Transepithelial Migration | 3 | 2024 | 100 | 1.050 |
Why?
|
| Receptors, CCR2 | 11 | 2020 | 214 | 1.010 |
Why?
|
| Respiratory Hypersensitivity | 7 | 2019 | 274 | 1.000 |
Why?
|
| Bronchoalveolar Lavage Fluid | 20 | 2013 | 755 | 0.920 |
Why?
|
| Receptors, Purinergic P2 | 7 | 2006 | 150 | 0.920 |
Why?
|
| HIV-1 | 19 | 2019 | 6858 | 0.910 |
Why?
|
| Signal Transduction | 40 | 2023 | 23415 | 0.880 |
Why?
|
| Lymphocytic Choriomeningitis | 3 | 2021 | 139 | 0.850 |
Why?
|
| Leukocytes | 13 | 2020 | 2024 | 0.840 |
Why?
|
| Receptors, Lysosphingolipid | 4 | 2017 | 122 | 0.840 |
Why?
|
| Chemotactic Factors, Eosinophil | 14 | 2001 | 40 | 0.840 |
Why?
|
| Ovalbumin | 17 | 2015 | 675 | 0.830 |
Why?
|
| Adoptive Transfer | 12 | 2016 | 818 | 0.820 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 10 | 2004 | 1650 | 0.810 |
Why?
|
| Cell Adhesion | 14 | 2019 | 3088 | 0.790 |
Why?
|
| Vagina | 5 | 2017 | 841 | 0.780 |
Why?
|
| Receptors, Cytokine | 10 | 2018 | 257 | 0.770 |
Why?
|
| Histamine Antagonists | 1 | 2021 | 92 | 0.750 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2021 | 177 | 0.750 |
Why?
|
| Ligands | 19 | 2021 | 3268 | 0.750 |
Why?
|
| Autoimmunity | 6 | 2023 | 1350 | 0.740 |
Why?
|
| Lymphocyte Activation | 23 | 2021 | 5463 | 0.740 |
Why?
|
| Chemokine CXCL1 | 2 | 2020 | 101 | 0.740 |
Why?
|
| Spleen | 8 | 2021 | 2286 | 0.730 |
Why?
|
| Integrin alpha1 | 1 | 2020 | 13 | 0.730 |
Why?
|
| Synaptotagmins | 2 | 2011 | 53 | 0.710 |
Why?
|
| Histamine | 2 | 2021 | 499 | 0.710 |
Why?
|
| Encephalitis, Viral | 1 | 2020 | 58 | 0.700 |
Why?
|
| Chemokine CCL8 | 4 | 2018 | 17 | 0.700 |
Why?
|
| Antigens | 12 | 2021 | 1441 | 0.700 |
Why?
|
| Endothelial Cells | 9 | 2019 | 3550 | 0.690 |
Why?
|
| Bronchial Hyperreactivity | 9 | 2013 | 302 | 0.680 |
Why?
|
| Chemokine CXCL11 | 15 | 2009 | 43 | 0.680 |
Why?
|
| Graft Rejection | 12 | 2013 | 4438 | 0.660 |
Why?
|
| Receptors, Lysophosphatidic Acid | 4 | 2016 | 77 | 0.630 |
Why?
|
| Chemotactic Factors | 5 | 2015 | 197 | 0.620 |
Why?
|
| Biological Factors | 1 | 2019 | 157 | 0.620 |
Why?
|
| Toll-Like Receptors | 6 | 2010 | 575 | 0.620 |
Why?
|
| Antigen-Presenting Cells | 3 | 2021 | 963 | 0.620 |
Why?
|
| Pulmonary Eosinophilia | 7 | 2011 | 78 | 0.610 |
Why?
|
| Mice, Transgenic | 32 | 2022 | 9526 | 0.600 |
Why?
|
| Immunization | 2 | 2020 | 1217 | 0.590 |
Why?
|
| Blood-Brain Barrier | 2 | 2024 | 1027 | 0.590 |
Why?
|
| HIV Infections | 18 | 2019 | 17342 | 0.580 |
Why?
|
| B-Lymphocytes | 8 | 2019 | 4745 | 0.570 |
Why?
|
| Arteritis | 1 | 2019 | 158 | 0.560 |
Why?
|
| Orthomyxoviridae Infections | 5 | 2015 | 254 | 0.560 |
Why?
|
| Mice, Inbred NOD | 13 | 2023 | 1827 | 0.550 |
Why?
|
| Killer Cells, Natural | 9 | 2010 | 2191 | 0.550 |
Why?
|
| Lectins, C-Type | 2 | 2020 | 584 | 0.550 |
Why?
|
| Bronchi | 6 | 2007 | 846 | 0.540 |
Why?
|
| Endothelium, Vascular | 13 | 2017 | 4433 | 0.540 |
Why?
|
| Receptors, Interleukin-8B | 4 | 2020 | 58 | 0.530 |
Why?
|
| Receptors, IgG | 6 | 2012 | 558 | 0.530 |
Why?
|
| Sphingosine | 4 | 2016 | 307 | 0.530 |
Why?
|
| Basophils | 4 | 2009 | 407 | 0.520 |
Why?
|
| Chemokine CCL11 | 29 | 2011 | 128 | 0.520 |
Why?
|
| Cells, Cultured | 41 | 2018 | 18937 | 0.510 |
Why?
|
| Adaptive Immunity | 3 | 2015 | 724 | 0.510 |
Why?
|
| Astrocytes | 2 | 2020 | 1341 | 0.510 |
Why?
|
| Fibroblasts | 10 | 2019 | 4140 | 0.500 |
Why?
|
| Receptors, Cell Surface | 5 | 2019 | 2802 | 0.500 |
Why?
|
| Membrane Glycoproteins | 8 | 2015 | 3688 | 0.500 |
Why?
|
| Immunotherapy | 6 | 2021 | 4642 | 0.490 |
Why?
|
| Chemokine CCL1 | 2 | 2014 | 20 | 0.490 |
Why?
|
| Dermatitis, Atopic | 3 | 2013 | 731 | 0.490 |
Why?
|
| Macrophages | 19 | 2019 | 5758 | 0.490 |
Why?
|
| T-Lymphocytes, Cytotoxic | 7 | 2021 | 1779 | 0.480 |
Why?
|
| Pulmonary Fibrosis | 7 | 2013 | 505 | 0.480 |
Why?
|
| Propylene Glycols | 3 | 2013 | 91 | 0.470 |
Why?
|
| Microglia | 5 | 2008 | 1357 | 0.470 |
Why?
|
| Mice, Inbred BALB C | 23 | 2017 | 6188 | 0.470 |
Why?
|
| Cell Proliferation | 17 | 2021 | 10429 | 0.470 |
Why?
|
| Bronchiolitis Obliterans | 2 | 2006 | 213 | 0.460 |
Why?
|
| Immunophenotyping | 10 | 2022 | 1864 | 0.460 |
Why?
|
| Genitalia, Female | 1 | 2015 | 147 | 0.460 |
Why?
|
| Influenza, Human | 2 | 2023 | 1521 | 0.450 |
Why?
|
| Receptors, CXCR4 | 12 | 2017 | 727 | 0.450 |
Why?
|
| Immunization, Passive | 1 | 2016 | 616 | 0.450 |
Why?
|
| Herpes Genitalis | 1 | 2015 | 149 | 0.450 |
Why?
|
| Down-Regulation | 7 | 2010 | 2916 | 0.440 |
Why?
|
| Herpesvirus 2, Human | 1 | 2015 | 191 | 0.440 |
Why?
|
| Humans | 193 | 2023 | 760740 | 0.440 |
Why?
|
| STAT6 Transcription Factor | 4 | 2009 | 194 | 0.440 |
Why?
|
| Pneumonia | 6 | 2020 | 2143 | 0.440 |
Why?
|
| Interleukin-1beta | 4 | 2019 | 998 | 0.430 |
Why?
|
| Chlamydia trachomatis | 1 | 2015 | 239 | 0.430 |
Why?
|
| Lung Injury | 4 | 2013 | 422 | 0.420 |
Why?
|
| Receptors, Lymphocyte Homing | 4 | 2012 | 141 | 0.420 |
Why?
|
| Models, Immunological | 6 | 2012 | 512 | 0.420 |
Why?
|
| Mucus | 5 | 2020 | 342 | 0.410 |
Why?
|
| Rheumatic Diseases | 1 | 2019 | 649 | 0.410 |
Why?
|
| Interleukin-4 | 7 | 2013 | 1146 | 0.410 |
Why?
|
| Mice, SCID | 12 | 2017 | 2625 | 0.400 |
Why?
|
| Lysophospholipids | 5 | 2016 | 337 | 0.400 |
Why?
|
| STAT1 Transcription Factor | 4 | 2015 | 340 | 0.400 |
Why?
|
| Immunity, Cellular | 6 | 2016 | 1550 | 0.400 |
Why?
|
| Neoplasms | 7 | 2021 | 22131 | 0.390 |
Why?
|
| Chlamydia Infections | 1 | 2015 | 365 | 0.380 |
Why?
|
| Toxoplasma | 5 | 2012 | 157 | 0.380 |
Why?
|
| Epithelium | 5 | 2013 | 1603 | 0.380 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2011 | 82 | 0.380 |
Why?
|
| Interleukin-23 | 1 | 2013 | 201 | 0.380 |
Why?
|
| Lung Transplantation | 3 | 2013 | 1310 | 0.380 |
Why?
|
| Aminoacyltransferases | 1 | 2011 | 52 | 0.370 |
Why?
|
| Gene Expression Regulation | 26 | 2016 | 11874 | 0.370 |
Why?
|
| Epitopes, T-Lymphocyte | 6 | 2024 | 825 | 0.360 |
Why?
|
| Natural Killer T-Cells | 3 | 2011 | 322 | 0.360 |
Why?
|
| Inflammation Mediators | 7 | 2015 | 1884 | 0.350 |
Why?
|
| Antibodies, Neutralizing | 3 | 2017 | 1936 | 0.350 |
Why?
|
| Skin | 12 | 2021 | 4472 | 0.350 |
Why?
|
| Interleukin-1alpha | 1 | 2010 | 86 | 0.350 |
Why?
|
| Virus Replication | 9 | 2016 | 2427 | 0.350 |
Why?
|
| HIV Antibodies | 3 | 2016 | 1302 | 0.350 |
Why?
|
| Arteriosclerosis | 4 | 2007 | 1056 | 0.350 |
Why?
|
| Molecular Sequence Data | 27 | 2014 | 17630 | 0.350 |
Why?
|
| Calcium | 19 | 2018 | 5717 | 0.350 |
Why?
|
| Islets of Langerhans Transplantation | 3 | 2004 | 740 | 0.340 |
Why?
|
| Antirheumatic Agents | 1 | 2019 | 1365 | 0.340 |
Why?
|
| Lupus Erythematosus, Systemic | 4 | 2022 | 2152 | 0.340 |
Why?
|
| RNA, Messenger | 40 | 2011 | 12759 | 0.330 |
Why?
|
| Interleukin-1 | 8 | 2023 | 1248 | 0.330 |
Why?
|
| Interleukin-8 | 6 | 2016 | 696 | 0.320 |
Why?
|
| Glycosaminoglycans | 5 | 2017 | 607 | 0.320 |
Why?
|
| Chemokine CCL19 | 3 | 2018 | 35 | 0.320 |
Why?
|
| Toxoplasmosis | 2 | 2006 | 94 | 0.320 |
Why?
|
| Autoantibodies | 6 | 2022 | 2115 | 0.320 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2004 | 823 | 0.310 |
Why?
|
| Cell Differentiation | 14 | 2021 | 11512 | 0.310 |
Why?
|
| Scavenger Receptors, Class F | 2 | 2022 | 16 | 0.310 |
Why?
|
| Epithelial Cells | 9 | 2016 | 3672 | 0.310 |
Why?
|
| Receptors, Interleukin-8A | 2 | 2005 | 47 | 0.300 |
Why?
|
| Synovial Fluid | 4 | 2018 | 393 | 0.300 |
Why?
|
| Receptors, Eicosanoid | 1 | 2007 | 12 | 0.300 |
Why?
|
| Disease Transmission, Infectious | 1 | 2013 | 561 | 0.300 |
Why?
|
| Flow Cytometry | 16 | 2016 | 5863 | 0.300 |
Why?
|
| Antibodies | 6 | 2011 | 2413 | 0.290 |
Why?
|
| Organ Specificity | 6 | 2015 | 1964 | 0.290 |
Why?
|
| Cell Migration Inhibition | 7 | 2013 | 97 | 0.290 |
Why?
|
| Autoimmune Diseases | 3 | 2018 | 2238 | 0.290 |
Why?
|
| Antibodies, Blocking | 4 | 2018 | 243 | 0.290 |
Why?
|
| Antigens, CD1 | 3 | 2006 | 439 | 0.280 |
Why?
|
| Interleukin-5 | 6 | 2013 | 269 | 0.280 |
Why?
|
| Amino Acid Sequence | 22 | 2014 | 13442 | 0.280 |
Why?
|
| Chemokine CXCL12 | 10 | 2017 | 454 | 0.270 |
Why?
|
| Endotoxins | 1 | 2009 | 520 | 0.270 |
Why?
|
| Lymphocytes | 7 | 2023 | 2604 | 0.270 |
Why?
|
| Immune System | 2 | 2014 | 791 | 0.270 |
Why?
|
| Isoenzymes | 1 | 2011 | 1687 | 0.270 |
Why?
|
| Neovascularization, Pathologic | 5 | 2014 | 2644 | 0.270 |
Why?
|
| Cell Line | 20 | 2013 | 15577 | 0.270 |
Why?
|
| Vaccines | 1 | 2015 | 838 | 0.270 |
Why?
|
| Lung Diseases | 4 | 2013 | 1909 | 0.260 |
Why?
|
| Tumor Microenvironment | 4 | 2021 | 3868 | 0.260 |
Why?
|
| Transplantation Tolerance | 1 | 2011 | 605 | 0.260 |
Why?
|
| Recombinant Proteins | 9 | 2006 | 6520 | 0.260 |
Why?
|
| Immunohistochemistry | 18 | 2016 | 11069 | 0.260 |
Why?
|
| Mice, Inbred Strains | 11 | 2012 | 1759 | 0.260 |
Why?
|
| Protein Binding | 12 | 2018 | 9345 | 0.260 |
Why?
|
| Plasmodium berghei | 3 | 2019 | 159 | 0.260 |
Why?
|
| Trachea | 5 | 2006 | 1089 | 0.250 |
Why?
|
| Psoriasis | 3 | 2013 | 944 | 0.250 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2005 | 340 | 0.250 |
Why?
|
| Chemokine CCL21 | 3 | 2017 | 50 | 0.250 |
Why?
|
| Neurons | 3 | 2020 | 9436 | 0.240 |
Why?
|
| Macrophages, Peritoneal | 2 | 2003 | 238 | 0.240 |
Why?
|
| Interferon-beta | 3 | 2017 | 345 | 0.240 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2019 | 541 | 0.240 |
Why?
|
| Phagocytosis | 5 | 2022 | 1526 | 0.240 |
Why?
|
| Bronchial Diseases | 1 | 2005 | 150 | 0.240 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2017 | 546 | 0.240 |
Why?
|
| Muscle, Smooth | 3 | 2016 | 927 | 0.230 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2004 | 1349 | 0.230 |
Why?
|
| Chemokine CCL5 | 5 | 2000 | 214 | 0.230 |
Why?
|
| HLA-DR Antigens | 3 | 2005 | 601 | 0.230 |
Why?
|
| Bleomycin | 7 | 2011 | 494 | 0.230 |
Why?
|
| Vitiligo | 2 | 2016 | 96 | 0.230 |
Why?
|
| Islets of Langerhans | 3 | 2023 | 1340 | 0.230 |
Why?
|
| Eosinophilia | 5 | 1999 | 559 | 0.230 |
Why?
|
| Synovial Membrane | 3 | 2016 | 532 | 0.230 |
Why?
|
| Up-Regulation | 10 | 2017 | 4117 | 0.220 |
Why?
|
| Myeloid Cells | 1 | 2009 | 823 | 0.220 |
Why?
|
| Cloning, Molecular | 10 | 2011 | 4172 | 0.220 |
Why?
|
| Candida albicans | 3 | 2019 | 372 | 0.220 |
Why?
|
| Vasculitis | 2 | 2019 | 522 | 0.220 |
Why?
|
| Trans-Activators | 4 | 2016 | 2851 | 0.220 |
Why?
|
| Stromal Cells | 5 | 2018 | 1329 | 0.220 |
Why?
|
| Granulocytes | 1 | 2005 | 551 | 0.220 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 2 | 2024 | 267 | 0.220 |
Why?
|
| RNA Interference | 2 | 2016 | 2829 | 0.220 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2024 | 65 | 0.220 |
Why?
|
| Antibodies, Antinuclear | 1 | 2005 | 342 | 0.220 |
Why?
|
| Female | 73 | 2021 | 392203 | 0.220 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 1229 | 0.210 |
Why?
|
| Base Sequence | 16 | 2016 | 12420 | 0.210 |
Why?
|
| Dose-Response Relationship, Immunologic | 3 | 2016 | 359 | 0.210 |
Why?
|
| Dengue Virus | 3 | 2013 | 201 | 0.210 |
Why?
|
| Transfection | 11 | 2016 | 5765 | 0.210 |
Why?
|
| Antigens, CD1d | 4 | 2010 | 228 | 0.210 |
Why?
|
| Arginine | 1 | 2006 | 933 | 0.210 |
Why?
|
| Herpesvirus 1, Human | 3 | 2024 | 739 | 0.210 |
Why?
|
| Tyrosine | 2 | 2006 | 1440 | 0.210 |
Why?
|
| Flagellin | 1 | 2003 | 124 | 0.200 |
Why?
|
| Permeability | 2 | 2024 | 721 | 0.200 |
Why?
|
| Macrophage Inflammatory Proteins | 4 | 1998 | 121 | 0.200 |
Why?
|
| Antithrombin III | 1 | 2002 | 128 | 0.200 |
Why?
|
| Gene Expression | 12 | 2013 | 7569 | 0.200 |
Why?
|
| Molecular Targeted Therapy | 4 | 2019 | 2812 | 0.200 |
Why?
|
| Transplantation, Homologous | 8 | 2006 | 4802 | 0.200 |
Why?
|
| Brain | 10 | 2018 | 27100 | 0.200 |
Why?
|
| Immunity, Active | 1 | 2002 | 58 | 0.200 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2023 | 299 | 0.200 |
Why?
|
| Growth Substances | 2 | 2003 | 768 | 0.200 |
Why?
|
| Receptors, CCR1 | 2 | 2012 | 30 | 0.200 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2017 | 3752 | 0.200 |
Why?
|
| Dengue | 3 | 2013 | 254 | 0.200 |
Why?
|
| Homeostasis | 4 | 2015 | 3321 | 0.190 |
Why?
|
| Alzheimer Disease | 4 | 2008 | 8603 | 0.190 |
Why?
|
| Hypertension, Pulmonary | 2 | 2011 | 1582 | 0.190 |
Why?
|
| Respiratory System | 3 | 2016 | 563 | 0.190 |
Why?
|
| Heart Transplantation | 5 | 2004 | 3233 | 0.190 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 2013 | 378 | 0.180 |
Why?
|
| Bone Marrow Cells | 5 | 2016 | 2409 | 0.180 |
Why?
|
| Microscopy, Fluorescence | 4 | 2016 | 2639 | 0.180 |
Why?
|
| Heart | 2 | 2013 | 4403 | 0.180 |
Why?
|
| Lipopolysaccharides | 6 | 2023 | 2202 | 0.180 |
Why?
|
| Amyloid beta-Peptides | 5 | 2008 | 3839 | 0.180 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2021 | 174 | 0.180 |
Why?
|
| Lymphocyte Subsets | 3 | 2013 | 310 | 0.180 |
Why?
|
| Receptors, CCR3 | 4 | 2006 | 62 | 0.180 |
Why?
|
| Immunoglobulin E | 9 | 2006 | 1502 | 0.180 |
Why?
|
| Lymphocyte Depletion | 3 | 2013 | 601 | 0.180 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2000 | 18 | 0.180 |
Why?
|
| Heparitin Sulfate | 2 | 2006 | 223 | 0.180 |
Why?
|
| Disease Susceptibility | 4 | 2022 | 1788 | 0.170 |
Why?
|
| Spores, Fungal | 1 | 2020 | 90 | 0.170 |
Why?
|
| Pyroglyphidae | 1 | 2020 | 89 | 0.170 |
Why?
|
| Heparin | 3 | 2003 | 1632 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2013 | 3798 | 0.170 |
Why?
|
| RNA, Small Interfering | 6 | 2017 | 3419 | 0.170 |
Why?
|
| Acyclovir | 1 | 2020 | 267 | 0.170 |
Why?
|
| DNA, Complementary | 7 | 2004 | 1989 | 0.170 |
Why?
|
| Receptors, Interferon | 2 | 2018 | 115 | 0.170 |
Why?
|
| Antigens, Ly | 2 | 2017 | 294 | 0.170 |
Why?
|
| Antigen Presentation | 4 | 2014 | 1250 | 0.160 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2016 | 2197 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 11 | 2017 | 9171 | 0.160 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2018 | 1692 | 0.160 |
Why?
|
| Interleukin-12 | 5 | 2021 | 577 | 0.160 |
Why?
|
| Antigens, CD | 5 | 2021 | 3998 | 0.160 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2016 | 91 | 0.160 |
Why?
|
| Peritonitis | 2 | 2003 | 368 | 0.160 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2005 | 614 | 0.160 |
Why?
|
| Duffy Blood-Group System | 1 | 2019 | 58 | 0.160 |
Why?
|
| Fever | 1 | 2006 | 1618 | 0.160 |
Why?
|
| Receptors, Immunologic | 4 | 2015 | 1409 | 0.160 |
Why?
|
| Lymphocyte Count | 5 | 2016 | 777 | 0.160 |
Why?
|
| Male | 61 | 2019 | 360402 | 0.160 |
Why?
|
| Receptors, CCR6 | 3 | 2012 | 74 | 0.160 |
Why?
|
| Receptors, Scavenger | 3 | 2009 | 123 | 0.150 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2019 | 1128 | 0.150 |
Why?
|
| Multiple Sclerosis | 2 | 2013 | 3222 | 0.150 |
Why?
|
| Melanoma, Experimental | 4 | 2016 | 561 | 0.150 |
Why?
|
| Lyme Disease | 3 | 2010 | 631 | 0.150 |
Why?
|
| Epitopes | 2 | 2022 | 2501 | 0.150 |
Why?
|
| Aspergillosis | 1 | 2020 | 242 | 0.150 |
Why?
|
| Integrin alpha Chains | 1 | 2018 | 95 | 0.150 |
Why?
|
| Transcriptional Activation | 2 | 2001 | 1754 | 0.150 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2009 | 89 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 12 | 2017 | 6126 | 0.150 |
Why?
|
| Viral Load | 5 | 2013 | 3325 | 0.150 |
Why?
|
| Epidermis | 3 | 2019 | 526 | 0.150 |
Why?
|
| Airway Remodeling | 1 | 2019 | 133 | 0.150 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 990 | 0.150 |
Why?
|
| Immunologic Surveillance | 1 | 2018 | 92 | 0.140 |
Why?
|
| Paracrine Communication | 1 | 2019 | 277 | 0.140 |
Why?
|
| Interleukins | 3 | 2015 | 783 | 0.140 |
Why?
|
| Cell Line, Transformed | 4 | 2006 | 866 | 0.140 |
Why?
|
| Receptors, OX40 | 1 | 2017 | 44 | 0.140 |
Why?
|
| Platelet Activation | 1 | 2001 | 646 | 0.140 |
Why?
|
| Neutrophil Activation | 1 | 2018 | 180 | 0.140 |
Why?
|
| Cerebellum | 2 | 2002 | 1501 | 0.140 |
Why?
|
| Transcription, Genetic | 10 | 2020 | 7583 | 0.140 |
Why?
|
| Cell Communication | 3 | 2021 | 1654 | 0.140 |
Why?
|
| Directed Molecular Evolution | 1 | 2018 | 161 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 3 | 2019 | 1962 | 0.140 |
Why?
|
| Platelet Factor 4 | 2 | 1995 | 129 | 0.140 |
Why?
|
| Orthomyxoviridae | 2 | 2015 | 149 | 0.140 |
Why?
|
| Blotting, Western | 6 | 2013 | 5034 | 0.140 |
Why?
|
| Chemokine CCL24 | 3 | 2013 | 8 | 0.140 |
Why?
|
| Species Specificity | 5 | 2014 | 2410 | 0.140 |
Why?
|
| Platelet Aggregation | 1 | 2000 | 771 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2023 | 3415 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 2 | 2019 | 2063 | 0.130 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2222 | 0.130 |
Why?
|
| Leishmania donovani | 1 | 2016 | 68 | 0.130 |
Why?
|
| Receptors, CCR | 1 | 2016 | 37 | 0.130 |
Why?
|
| Dexamethasone | 3 | 2000 | 1946 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 1608 | 0.130 |
Why?
|
| Cell Lineage | 5 | 2012 | 2553 | 0.130 |
Why?
|
| HIV | 3 | 2016 | 1580 | 0.130 |
Why?
|
| Chemokine CCL22 | 2 | 2009 | 27 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 1896 | 0.130 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2016 | 99 | 0.130 |
Why?
|
| Chemokine CCL17 | 2 | 2009 | 26 | 0.130 |
Why?
|
| Reperfusion Injury | 3 | 2008 | 1023 | 0.130 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2015 | 53 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1997 | 418 | 0.130 |
Why?
|
| Chromosome Mapping | 6 | 1999 | 4611 | 0.130 |
Why?
|
| CARD Signaling Adaptor Proteins | 3 | 2020 | 159 | 0.130 |
Why?
|
| Viral Envelope Proteins | 1 | 1999 | 640 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 858 | 0.130 |
Why?
|
| Respiratory Mucosa | 3 | 2006 | 438 | 0.130 |
Why?
|
| L-Selectin | 3 | 2008 | 211 | 0.130 |
Why?
|
| Nasal Mucosa | 5 | 2006 | 415 | 0.130 |
Why?
|
| Mucous Membrane | 1 | 2019 | 659 | 0.120 |
Why?
|
| Cytoplasmic Granules | 1 | 1998 | 573 | 0.120 |
Why?
|
| Mast Cells | 3 | 2013 | 1392 | 0.120 |
Why?
|
| Terminology as Topic | 2 | 2020 | 1528 | 0.120 |
Why?
|
| Liver | 6 | 2016 | 7512 | 0.120 |
Why?
|
| Myocardial Infarction | 2 | 2013 | 11458 | 0.120 |
Why?
|
| Exodeoxyribonucleases | 1 | 2016 | 191 | 0.120 |
Why?
|
| Proteoglycans | 1 | 1998 | 803 | 0.120 |
Why?
|
| Ureteral Obstruction | 1 | 2016 | 293 | 0.120 |
Why?
|
| Protein Synthesis Inhibitors | 3 | 2000 | 189 | 0.120 |
Why?
|
| Tomography, Optical Coherence | 3 | 2019 | 2917 | 0.120 |
Why?
|
| Adiponectin | 3 | 2011 | 1107 | 0.120 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 536 | 0.110 |
Why?
|
| Bone Marrow | 3 | 2016 | 2909 | 0.110 |
Why?
|
| Biological Transport | 3 | 2011 | 2089 | 0.110 |
Why?
|
| Leukocyte Count | 4 | 2016 | 1597 | 0.110 |
Why?
|
| Inflammasomes | 1 | 2019 | 526 | 0.110 |
Why?
|
| Silicon Dioxide | 1 | 2015 | 216 | 0.110 |
Why?
|
| Panniculitis | 1 | 2014 | 45 | 0.110 |
Why?
|
| Fetus | 3 | 2002 | 1862 | 0.110 |
Why?
|
| Virulence Factors, Bordetella | 3 | 2002 | 154 | 0.110 |
Why?
|
| Genes | 3 | 1989 | 1823 | 0.110 |
Why?
|
| Binding Sites | 6 | 2007 | 6051 | 0.110 |
Why?
|
| Pertussis Toxin | 3 | 2002 | 176 | 0.110 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2015 | 165 | 0.110 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2013 | 35 | 0.110 |
Why?
|
| Macrophage Activation | 5 | 2010 | 552 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2017 | 2048 | 0.110 |
Why?
|
| Phenotype | 9 | 2016 | 16572 | 0.110 |
Why?
|
| Carotid Artery Diseases | 1 | 2000 | 877 | 0.110 |
Why?
|
| Peritoneal Fibrosis | 1 | 2013 | 9 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2002 | 1834 | 0.110 |
Why?
|
| Serine | 2 | 2014 | 830 | 0.110 |
Why?
|
| Integrin alpha4 | 1 | 2013 | 87 | 0.110 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2015 | 584 | 0.110 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2005 | 193 | 0.110 |
Why?
|
| Gene Knockout Techniques | 2 | 2013 | 802 | 0.110 |
Why?
|
| Antiviral Agents | 2 | 2002 | 3037 | 0.100 |
Why?
|
| Listeriosis | 1 | 2014 | 148 | 0.100 |
Why?
|
| Radiation Chimera | 1 | 2012 | 215 | 0.100 |
Why?
|
| Crosses, Genetic | 3 | 2015 | 750 | 0.100 |
Why?
|
| Aorta | 2 | 2019 | 2041 | 0.100 |
Why?
|
| Injections, Intraperitoneal | 3 | 2002 | 412 | 0.100 |
Why?
|
| Pericytes | 1 | 2015 | 294 | 0.100 |
Why?
|
| Bronchoscopy | 3 | 2019 | 909 | 0.100 |
Why?
|
| Lymphotoxin-alpha | 1 | 2012 | 93 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2016 | 10754 | 0.100 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2007 | 2423 | 0.100 |
Why?
|
| Giant Cell Arteritis | 1 | 2016 | 306 | 0.100 |
Why?
|
| Prostaglandin D2 | 2 | 2004 | 108 | 0.100 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2013 | 141 | 0.100 |
Why?
|
| Leukotrienes | 1 | 2013 | 231 | 0.100 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2019 | 831 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2016 | 3394 | 0.100 |
Why?
|
| Immunoglobulin G | 8 | 2022 | 4533 | 0.100 |
Why?
|
| Listeria monocytogenes | 1 | 2014 | 247 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2017 | 3492 | 0.100 |
Why?
|
| Apoptosis | 4 | 2013 | 9476 | 0.100 |
Why?
|
| Transcription Factors | 5 | 2016 | 12116 | 0.100 |
Why?
|
| Genes, vif | 1 | 2011 | 15 | 0.100 |
Why?
|
| Cervix Uteri | 2 | 2016 | 570 | 0.100 |
Why?
|
| Kinetics | 6 | 2006 | 6370 | 0.100 |
Why?
|
| Nephritis | 2 | 2013 | 145 | 0.100 |
Why?
|
| Immunity, Mucosal | 1 | 2015 | 483 | 0.100 |
Why?
|
| Genes, gag | 1 | 2011 | 55 | 0.100 |
Why?
|
| Obesity | 3 | 2014 | 12934 | 0.100 |
Why?
|
| Acute Disease | 6 | 2005 | 7236 | 0.090 |
Why?
|
| Cell Division | 5 | 2004 | 4457 | 0.090 |
Why?
|
| Pulmonary Artery | 2 | 2011 | 1927 | 0.090 |
Why?
|
| Kidney Diseases | 2 | 2016 | 2090 | 0.090 |
Why?
|
| Thymus Gland | 4 | 2006 | 1243 | 0.090 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2011 | 25 | 0.090 |
Why?
|
| Microscopy | 1 | 2016 | 905 | 0.090 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2003 | 888 | 0.090 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2011 | 138 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2014 | 346 | 0.090 |
Why?
|
| Toxoplasmosis, Ocular | 1 | 2011 | 29 | 0.090 |
Why?
|
| Lymph | 2 | 2014 | 77 | 0.090 |
Why?
|
| Joints | 1 | 2012 | 322 | 0.090 |
Why?
|
| CD40 Ligand | 1 | 2012 | 521 | 0.090 |
Why?
|
| Chorioretinitis | 1 | 2011 | 43 | 0.090 |
Why?
|
| Conserved Sequence | 2 | 2009 | 1162 | 0.090 |
Why?
|
| Reactive Oxygen Species | 4 | 2020 | 2137 | 0.090 |
Why?
|
| Graft vs Host Disease | 4 | 2016 | 3026 | 0.090 |
Why?
|
| Receptors, CXCR | 1 | 2011 | 52 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2009 | 1492 | 0.090 |
Why?
|
| Blood Proteins | 3 | 2002 | 1172 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3599 | 0.090 |
Why?
|
| Cricetinae | 4 | 2017 | 2424 | 0.090 |
Why?
|
| Sequence Alignment | 3 | 2003 | 2178 | 0.090 |
Why?
|
| Intestinal Mucosa | 2 | 2002 | 3031 | 0.090 |
Why?
|
| Dermatitis | 1 | 2012 | 202 | 0.090 |
Why?
|
| Chemokine CCL4 | 4 | 1998 | 126 | 0.090 |
Why?
|
| Syndecan-4 | 1 | 2010 | 45 | 0.090 |
Why?
|
| Myofibroblasts | 3 | 2019 | 223 | 0.090 |
Why?
|
| Synaptotagmin II | 1 | 2010 | 14 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2017 | 1117 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2011 | 1250 | 0.090 |
Why?
|
| Interferons | 2 | 2020 | 702 | 0.090 |
Why?
|
| Administration, Inhalation | 1 | 2013 | 1156 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2022 | 15829 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2013 | 0.090 |
Why?
|
| Bronchial Provocation Tests | 2 | 2019 | 216 | 0.090 |
Why?
|
| Myocardium | 2 | 2019 | 4725 | 0.090 |
Why?
|
| Clone Cells | 4 | 2003 | 1657 | 0.090 |
Why?
|
| Luminescent Proteins | 1 | 2012 | 836 | 0.090 |
Why?
|
| Receptors, Leukotriene | 1 | 2010 | 95 | 0.090 |
Why?
|
| Egg Proteins | 2 | 2006 | 57 | 0.090 |
Why?
|
| RANK Ligand | 1 | 2011 | 318 | 0.080 |
Why?
|
| Aptamers, Nucleotide | 1 | 2011 | 164 | 0.080 |
Why?
|
| Trichuris | 1 | 2009 | 32 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2015 | 1112 | 0.080 |
Why?
|
| Hepatic Stellate Cells | 1 | 2010 | 119 | 0.080 |
Why?
|
| Chronic Disease | 4 | 2021 | 9310 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2016 | 3205 | 0.080 |
Why?
|
| Blotting, Northern | 4 | 2006 | 1545 | 0.080 |
Why?
|
| Membrane Fusion | 1 | 2011 | 266 | 0.080 |
Why?
|
| Interferon-alpha | 1 | 2013 | 901 | 0.080 |
Why?
|
| Interleukin-2 | 2 | 2013 | 1888 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 4 | 2010 | 6074 | 0.080 |
Why?
|
| Coronary Vessels | 2 | 2019 | 3095 | 0.080 |
Why?
|
| Proteins | 6 | 2013 | 6030 | 0.080 |
Why?
|
| Plasmids | 3 | 2004 | 2265 | 0.080 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2011 | 250 | 0.080 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2024 | 1434 | 0.080 |
Why?
|
| In Situ Hybridization | 4 | 2000 | 1900 | 0.080 |
Why?
|
| Borrelia burgdorferi | 1 | 2010 | 183 | 0.080 |
Why?
|
| Survival Rate | 3 | 2008 | 12719 | 0.080 |
Why?
|
| Lung Compliance | 1 | 2009 | 200 | 0.080 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2010 | 304 | 0.080 |
Why?
|
| Transplantation Chimera | 1 | 2011 | 593 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2003 | 4340 | 0.080 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2009 | 1228 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 504 | 0.080 |
Why?
|
| Ectromelia virus | 1 | 2007 | 5 | 0.080 |
Why?
|
| Cryptococcus neoformans | 1 | 2009 | 120 | 0.080 |
Why?
|
| Vascular Diseases | 2 | 2010 | 1159 | 0.080 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2001 | 347 | 0.080 |
Why?
|
| Gene Library | 1 | 2011 | 1055 | 0.070 |
Why?
|
| Calcium Signaling | 2 | 2011 | 734 | 0.070 |
Why?
|
| Antigen-Antibody Complex | 3 | 2005 | 509 | 0.070 |
Why?
|
| Aspergillus fumigatus | 2 | 2020 | 157 | 0.070 |
Why?
|
| Rhinitis, Allergic, Seasonal | 2 | 1999 | 104 | 0.070 |
Why?
|
| Receptors, HIV | 2 | 1999 | 158 | 0.070 |
Why?
|
| Interleukin-17 | 2 | 2016 | 911 | 0.070 |
Why?
|
| Airway Resistance | 1 | 2009 | 406 | 0.070 |
Why?
|
| Erythema Chronicum Migrans | 1 | 2008 | 48 | 0.070 |
Why?
|
| Acrodermatitis | 1 | 2007 | 15 | 0.070 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 1079 | 0.070 |
Why?
|
| Borrelia | 1 | 2008 | 66 | 0.070 |
Why?
|
| Pseudolymphoma | 1 | 2007 | 30 | 0.070 |
Why?
|
| Cell Membrane | 4 | 2006 | 3680 | 0.070 |
Why?
|
| Chitin | 1 | 2007 | 33 | 0.070 |
Why?
|
| Keratinocytes | 4 | 2016 | 790 | 0.070 |
Why?
|
| Biopsy | 3 | 2016 | 6763 | 0.070 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1987 | 58 | 0.070 |
Why?
|
| Communicable Diseases | 1 | 2016 | 871 | 0.070 |
Why?
|
| Protein Biosynthesis | 3 | 1998 | 2100 | 0.070 |
Why?
|
| Antibody Formation | 2 | 2009 | 1390 | 0.070 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2007 | 34 | 0.070 |
Why?
|
| Drug Synergism | 2 | 2002 | 1756 | 0.070 |
Why?
|
| Lymphocyte Culture Test, Mixed | 3 | 2002 | 507 | 0.070 |
Why?
|
| Scleroderma, Systemic | 1 | 2011 | 344 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2445 | 0.070 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 16968 | 0.070 |
Why?
|
| Kidney | 3 | 2016 | 7044 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2023 | 578 | 0.070 |
Why?
|
| Wound Healing | 1 | 1998 | 2802 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2010 | 1646 | 0.070 |
Why?
|
| Rabbits | 3 | 1999 | 4770 | 0.070 |
Why?
|
| Influenza Vaccines | 1 | 2014 | 767 | 0.070 |
Why?
|
| Intestine, Small | 2 | 2004 | 1207 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2447 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2270 | 0.070 |
Why?
|
| Histamine Release | 2 | 1996 | 134 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2010 | 898 | 0.070 |
Why?
|
| Chemokine CXCL6 | 1 | 2006 | 14 | 0.070 |
Why?
|
| Intubation, Intratracheal | 2 | 2006 | 1331 | 0.070 |
Why?
|
| Phosphorylation | 4 | 2022 | 8311 | 0.070 |
Why?
|
| BCG Vaccine | 2 | 2000 | 369 | 0.070 |
Why?
|
| Culture Media, Conditioned | 3 | 2003 | 522 | 0.070 |
Why?
|
| Hybridization, Genetic | 1 | 2006 | 102 | 0.070 |
Why?
|
| Graft vs Host Reaction | 1 | 2006 | 99 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2004 | 813 | 0.070 |
Why?
|
| Colon | 2 | 2012 | 1791 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4569 | 0.070 |
Why?
|
| Bronchoalveolar Lavage | 3 | 2011 | 129 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 1999 | 2747 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1987 | 375 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2005 | 1970 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1987 | 410 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 14599 | 0.060 |
Why?
|
| Survival | 1 | 2006 | 161 | 0.060 |
Why?
|
| Erythema | 1 | 2007 | 262 | 0.060 |
Why?
|
| Phylogeny | 1 | 2013 | 2805 | 0.060 |
Why?
|
| Aortic Rupture | 1 | 2009 | 319 | 0.060 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2009 | 345 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2011 | 699 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2009 | 539 | 0.060 |
Why?
|
| Interferon Type I | 2 | 2015 | 557 | 0.060 |
Why?
|
| DNA, Protozoan | 1 | 2006 | 228 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3794 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 3 | 2009 | 2690 | 0.060 |
Why?
|
| Hyperplasia | 1 | 2009 | 1150 | 0.060 |
Why?
|
| Granuloma | 2 | 2016 | 327 | 0.060 |
Why?
|
| Cycloheximide | 2 | 2000 | 343 | 0.060 |
Why?
|
| Mice, Inbred CBA | 3 | 2011 | 436 | 0.060 |
Why?
|
| West Nile Fever | 1 | 2005 | 75 | 0.060 |
Why?
|
| West Nile virus | 1 | 2005 | 77 | 0.060 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2005 | 191 | 0.060 |
Why?
|
| Helicobacter felis | 1 | 2004 | 1 | 0.060 |
Why?
|
| HEK293 Cells | 3 | 2019 | 4269 | 0.060 |
Why?
|
| Influenza A virus | 1 | 2008 | 458 | 0.060 |
Why?
|
| Viral Proteins | 2 | 2013 | 1799 | 0.060 |
Why?
|
| Fibrosis | 4 | 2016 | 2047 | 0.060 |
Why?
|
| Peptides | 3 | 2024 | 4354 | 0.060 |
Why?
|
| Growth Inhibitors | 2 | 2006 | 375 | 0.060 |
Why?
|
| Disease Progression | 4 | 2015 | 13495 | 0.060 |
Why?
|
| Receptors, Prostaglandin | 1 | 2004 | 53 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2009 | 1135 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 315 | 0.060 |
Why?
|
| Transplantation, Isogeneic | 2 | 2002 | 248 | 0.060 |
Why?
|
| Ribonucleases | 2 | 2006 | 277 | 0.060 |
Why?
|
| Klebsiella Infections | 1 | 2005 | 144 | 0.060 |
Why?
|
| Spinal Cord | 2 | 2004 | 1807 | 0.060 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2004 | 57 | 0.060 |
Why?
|
| Peroxidases | 2 | 2002 | 134 | 0.060 |
Why?
|
| CHO Cells | 2 | 1998 | 1387 | 0.060 |
Why?
|
| Food Hypersensitivity | 1 | 2012 | 726 | 0.060 |
Why?
|
| Arrestins | 1 | 2004 | 73 | 0.060 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2007 | 2567 | 0.060 |
Why?
|
| Nucleocapsid | 1 | 2024 | 63 | 0.060 |
Why?
|
| T-Box Domain Proteins | 1 | 2006 | 469 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 4910 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 4 | 2016 | 5780 | 0.060 |
Why?
|
| Simian immunodeficiency virus | 2 | 2019 | 810 | 0.060 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1987 | 790 | 0.060 |
Why?
|
| Cell Polarity | 2 | 2011 | 635 | 0.060 |
Why?
|
| Cell Survival | 3 | 2021 | 5780 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2006 | 630 | 0.060 |
Why?
|
| Klebsiella pneumoniae | 1 | 2005 | 249 | 0.060 |
Why?
|
| Receptors, Fc | 4 | 1989 | 534 | 0.060 |
Why?
|
| Gene Expression Profiling | 3 | 2022 | 9417 | 0.050 |
Why?
|
| Dynamins | 1 | 2004 | 139 | 0.050 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2003 | 48 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 2007 | 465 | 0.050 |
Why?
|
| Endothelium | 2 | 2004 | 764 | 0.050 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2003 | 67 | 0.050 |
Why?
|
| Decidua | 1 | 2003 | 82 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2004 | 465 | 0.050 |
Why?
|
| Protein Transport | 2 | 2016 | 1966 | 0.050 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2003 | 42 | 0.050 |
Why?
|
| Phagocytes | 2 | 2022 | 295 | 0.050 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2003 | 221 | 0.050 |
Why?
|
| Binding Sites, Antibody | 1 | 2003 | 337 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2022 | 1242 | 0.050 |
Why?
|
| Granzymes | 2 | 2010 | 277 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 2004 | 238 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2007 | 6223 | 0.050 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2003 | 97 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2011 | 2008 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2005 | 597 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2017 | 2261 | 0.050 |
Why?
|
| Pneumonia, Bacterial | 1 | 2005 | 315 | 0.050 |
Why?
|
| Murine hepatitis virus | 1 | 2002 | 19 | 0.050 |
Why?
|
| Macaca mulatta | 2 | 2019 | 2328 | 0.050 |
Why?
|
| Monokines | 2 | 1999 | 71 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2003 | 1336 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5304 | 0.050 |
Why?
|
| Encephalomyelitis | 1 | 2002 | 36 | 0.050 |
Why?
|
| Superoxides | 1 | 2003 | 387 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2014 | 3310 | 0.050 |
Why?
|
| Macrophages, Alveolar | 3 | 1999 | 411 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2006 | 1971 | 0.050 |
Why?
|
| Multigene Family | 2 | 1997 | 1076 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2006 | 1081 | 0.050 |
Why?
|
| Time Factors | 10 | 2014 | 39908 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2000 | 2481 | 0.050 |
Why?
|
| Atherosclerosis | 3 | 2009 | 3400 | 0.050 |
Why?
|
| Cell-Free System | 2 | 1999 | 339 | 0.050 |
Why?
|
| Receptors, Lipoprotein | 1 | 2002 | 88 | 0.050 |
Why?
|
| Dermatitis, Contact | 1 | 2002 | 133 | 0.050 |
Why?
|
| Lung Neoplasms | 5 | 2015 | 13383 | 0.050 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2002 | 139 | 0.050 |
Why?
|
| Antibody Specificity | 2 | 2000 | 1057 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 7995 | 0.050 |
Why?
|
| Chemokine CCL3 | 2 | 1998 | 84 | 0.050 |
Why?
|
| Translocation, Genetic | 1 | 1987 | 1392 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 624 | 0.050 |
Why?
|
| Integrins | 2 | 2003 | 834 | 0.050 |
Why?
|
| Eosinophil Peroxidase | 1 | 2000 | 21 | 0.050 |
Why?
|
| Cell Aggregation | 1 | 2021 | 239 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2022 | 188 | 0.050 |
Why?
|
| GTP-Binding Proteins | 2 | 2003 | 949 | 0.050 |
Why?
|
| Benzylamines | 2 | 2017 | 246 | 0.050 |
Why?
|
| Heterocyclic Compounds | 2 | 2017 | 245 | 0.050 |
Why?
|
| Graft Survival | 2 | 2002 | 3814 | 0.050 |
Why?
|
| Helicobacter Infections | 1 | 2004 | 391 | 0.050 |
Why?
|
| Thioglycolates | 1 | 2000 | 37 | 0.050 |
Why?
|
| Ear | 1 | 2021 | 172 | 0.050 |
Why?
|
| Adult | 21 | 2019 | 220995 | 0.050 |
Why?
|
| Microbodies | 1 | 2000 | 36 | 0.040 |
Why?
|
| Interleukin-15 | 1 | 2021 | 185 | 0.040 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2000 | 107 | 0.040 |
Why?
|
| Regeneration | 1 | 2009 | 1505 | 0.040 |
Why?
|
| Antineoplastic Agents | 3 | 2017 | 13635 | 0.040 |
Why?
|
| Lipids | 1 | 2011 | 3332 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 1880 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 678 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2004 | 676 | 0.040 |
Why?
|
| Venules | 1 | 2000 | 161 | 0.040 |
Why?
|
| Chemokine CXCL13 | 2 | 2012 | 59 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2004 | 3793 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2010 | 1927 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2007 | 2200 | 0.040 |
Why?
|
| Myelin Proteins | 1 | 2000 | 209 | 0.040 |
Why?
|
| Penicillamine | 1 | 1999 | 60 | 0.040 |
Why?
|
| Ion Transport | 1 | 2001 | 320 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2005 | 1077 | 0.040 |
Why?
|
| Interleukin-10 | 3 | 2013 | 1171 | 0.040 |
Why?
|
| Integrin alphaV | 1 | 2019 | 54 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2003 | 799 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2009 | 1452 | 0.040 |
Why?
|
| Isoantigens | 1 | 2002 | 551 | 0.040 |
Why?
|
| Aerosols | 1 | 2002 | 635 | 0.040 |
Why?
|
| Demyelinating Diseases | 1 | 2002 | 352 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2008 | 1297 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3802 | 0.040 |
Why?
|
| Cornea | 1 | 2007 | 1332 | 0.040 |
Why?
|
| Ethmoid Sinusitis | 1 | 1998 | 25 | 0.040 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2019 | 59 | 0.040 |
Why?
|
| Myocarditis | 1 | 2006 | 788 | 0.040 |
Why?
|
| Peptide Fragments | 3 | 2006 | 5109 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2003 | 760 | 0.040 |
Why?
|
| Guinea Pigs | 2 | 1998 | 1310 | 0.040 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2019 | 153 | 0.040 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 148 | 0.040 |
Why?
|
| CpG Islands | 1 | 2003 | 1192 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2016 | 22153 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2012 | 691 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2006 | 2659 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 2 | 2000 | 1703 | 0.040 |
Why?
|
| Biological Products | 1 | 1987 | 912 | 0.040 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2018 | 50 | 0.040 |
Why?
|
| p21-Activated Kinases | 1 | 2019 | 127 | 0.040 |
Why?
|
| Models, Biological | 3 | 2015 | 9461 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2002 | 602 | 0.040 |
Why?
|
| Goblet Cells | 1 | 2001 | 298 | 0.040 |
Why?
|
| Sinusitis | 2 | 1997 | 991 | 0.040 |
Why?
|
| Biotinylation | 1 | 2018 | 184 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 2002 | 521 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2006 | 1600 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6927 | 0.040 |
Why?
|
| Vaccination | 2 | 2014 | 3370 | 0.040 |
Why?
|
| Transplantation Conditioning | 1 | 2004 | 1590 | 0.040 |
Why?
|
| Endocytosis | 1 | 2001 | 955 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2008 | 2878 | 0.040 |
Why?
|
| Actins | 2 | 2019 | 2051 | 0.040 |
Why?
|
| DNA Restriction Enzymes | 2 | 1987 | 550 | 0.040 |
Why?
|
| Chemokine CX3CL1 | 1 | 2017 | 62 | 0.040 |
Why?
|
| Glycosylation | 2 | 2014 | 1098 | 0.040 |
Why?
|
| Saphenous Vein | 1 | 2000 | 516 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 4021 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 2018 | 297 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2000 | 837 | 0.030 |
Why?
|
| Collagen | 1 | 2005 | 2634 | 0.030 |
Why?
|
| Birefringence | 1 | 2016 | 54 | 0.030 |
Why?
|
| Colitis | 1 | 2005 | 1234 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2016 | 84 | 0.030 |
Why?
|
| Serum Response Factor | 1 | 2016 | 78 | 0.030 |
Why?
|
| Methionine | 1 | 1999 | 572 | 0.030 |
Why?
|
| Cell Count | 3 | 2011 | 1834 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 110 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2018 | 1141 | 0.030 |
Why?
|
| Cattle | 1 | 2002 | 3841 | 0.030 |
Why?
|
| Muscle Relaxation | 1 | 2016 | 138 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2001 | 768 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2013 | 6345 | 0.030 |
Why?
|
| Apolipoproteins E | 3 | 2007 | 1443 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2000 | 561 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1988 | 1301 | 0.030 |
Why?
|
| Rats | 5 | 2012 | 23716 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2003 | 3965 | 0.030 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2016 | 63 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2012 | 2546 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1997 | 1058 | 0.030 |
Why?
|
| Viremia | 1 | 2019 | 706 | 0.030 |
Why?
|
| Depression, Chemical | 1 | 1995 | 184 | 0.030 |
Why?
|
| Respiratory Mechanics | 1 | 1999 | 699 | 0.030 |
Why?
|
| Dermatan Sulfate | 1 | 1995 | 43 | 0.030 |
Why?
|
| Muscles | 1 | 2000 | 1573 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2016 | 306 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2004 | 1894 | 0.030 |
Why?
|
| E-Selectin | 3 | 2005 | 577 | 0.030 |
Why?
|
| Mice, Mutant Strains | 3 | 2006 | 1748 | 0.030 |
Why?
|
| HLA-B Antigens | 2 | 2012 | 317 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 9586 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1995 | 221 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 2467 | 0.030 |
Why?
|
| Factor Xa | 1 | 1996 | 166 | 0.030 |
Why?
|
| Antioxidants | 1 | 2023 | 1669 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 428 | 0.030 |
Why?
|
| Surface Properties | 1 | 2018 | 1162 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2015 | 153 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 1614 | 0.030 |
Why?
|
| Cell Separation | 3 | 2010 | 1718 | 0.030 |
Why?
|
| Chimera | 1 | 2016 | 453 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1999 | 914 | 0.030 |
Why?
|
| Cholesterol | 1 | 2004 | 2902 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 1996 | 425 | 0.030 |
Why?
|
| Survival Analysis | 3 | 2015 | 10072 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 858 | 0.030 |
Why?
|
| Escherichia coli | 3 | 1996 | 4210 | 0.030 |
Why?
|
| Heart Failure | 1 | 2019 | 11670 | 0.030 |
Why?
|
| Plasmacytoma | 1 | 1995 | 171 | 0.030 |
Why?
|
| Transgenes | 1 | 2018 | 1008 | 0.030 |
Why?
|
| Antigens, Protozoan | 1 | 2016 | 316 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 289 | 0.030 |
Why?
|
| Crystallization | 1 | 2015 | 533 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 1683 | 0.030 |
Why?
|
| Aortic Diseases | 1 | 2000 | 735 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2003 | 2049 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2013 | 86 | 0.030 |
Why?
|
| Ticks | 1 | 2013 | 70 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1995 | 3730 | 0.030 |
Why?
|
| Tumor Necrosis Factors | 1 | 2013 | 107 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2000 | 907 | 0.030 |
Why?
|
| Cricetulus | 1 | 1995 | 814 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2016 | 616 | 0.030 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2013 | 128 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2000 | 1333 | 0.030 |
Why?
|
| Complement C1q | 1 | 2013 | 93 | 0.030 |
Why?
|
| Sarcoidosis | 1 | 1998 | 520 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2000 | 1349 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2001 | 1248 | 0.030 |
Why?
|
| Cartilage | 1 | 2016 | 806 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 1998 | 1022 | 0.030 |
Why?
|
| Middle Aged | 13 | 2016 | 220603 | 0.030 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2012 | 93 | 0.030 |
Why?
|
| Aedes | 1 | 2013 | 99 | 0.030 |
Why?
|
| Injections, Subcutaneous | 2 | 2006 | 671 | 0.030 |
Why?
|
| DNA Primers | 1 | 1997 | 2817 | 0.030 |
Why?
|
| Membrane Proteins | 4 | 2009 | 7847 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 1890 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 704 | 0.020 |
Why?
|
| Giant Cells | 1 | 2012 | 188 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 682 | 0.020 |
Why?
|
| DNA | 4 | 1997 | 7196 | 0.020 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2012 | 113 | 0.020 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2011 | 117 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2016 | 1200 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2003 | 472 | 0.020 |
Why?
|
| Dogs | 1 | 2016 | 3837 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1998 | 782 | 0.020 |
Why?
|
| Chlorhexidine | 1 | 2013 | 160 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1991 | 216 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2016 | 1878 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2003 | 476 | 0.020 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1991 | 135 | 0.020 |
Why?
|
| Mitogens | 1 | 2011 | 229 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2011 | 135 | 0.020 |
Why?
|
| Isoxazoles | 1 | 2013 | 232 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 2006 | 2010 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2011 | 149 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 2509 | 0.020 |
Why?
|
| RNA | 3 | 2006 | 2713 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2012 | 399 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 2009 | 1606 | 0.020 |
Why?
|
| Carbon Tetrachloride | 1 | 2010 | 72 | 0.020 |
Why?
|
| Chemokine CCL7 | 2 | 2001 | 30 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1993 | 506 | 0.020 |
Why?
|
| Hamartoma | 1 | 2013 | 236 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 1999 | 2135 | 0.020 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1997 | 1348 | 0.020 |
Why?
|
| Rhinitis | 1 | 1998 | 747 | 0.020 |
Why?
|
| Mutation | 3 | 2004 | 30015 | 0.020 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2013 | 262 | 0.020 |
Why?
|
| Cats | 1 | 2011 | 974 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2014 | 988 | 0.020 |
Why?
|
| G1 Phase | 1 | 1991 | 403 | 0.020 |
Why?
|
| Melanoma | 2 | 2021 | 5696 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 2010 | 94 | 0.020 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2010 | 112 | 0.020 |
Why?
|
| Anilides | 1 | 2013 | 411 | 0.020 |
Why?
|
| Remission Induction | 1 | 2015 | 2391 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 64572 | 0.020 |
Why?
|
| beta-Alanine | 1 | 2010 | 82 | 0.020 |
Why?
|
| Umbilical Veins | 2 | 2000 | 426 | 0.020 |
Why?
|
| Antigens, CD34 | 2 | 2003 | 658 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 794 | 0.020 |
Why?
|
| Calorimetry | 1 | 2008 | 129 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1988 | 174 | 0.020 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2013 | 517 | 0.020 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2008 | 53 | 0.020 |
Why?
|
| Cryptococcosis | 1 | 2009 | 103 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2008 | 173 | 0.020 |
Why?
|
| Carrier Proteins | 2 | 2013 | 4937 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2000 | 3027 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2013 | 1007 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2013 | 1170 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 1914 | 0.020 |
Why?
|
| Injections, Intradermal | 1 | 1987 | 116 | 0.020 |
Why?
|
| Drug Eruptions | 1 | 1991 | 335 | 0.020 |
Why?
|
| beta-Thromboglobulin | 1 | 1987 | 20 | 0.020 |
Why?
|
| Galectin 3 | 1 | 2009 | 240 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8165 | 0.020 |
Why?
|
| Protozoan Proteins | 1 | 2013 | 846 | 0.020 |
Why?
|
| Austria | 1 | 2008 | 206 | 0.020 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2013 | 556 | 0.020 |
Why?
|
| Anti-HIV Agents | 2 | 2003 | 4524 | 0.020 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 6483 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 2703 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 1745 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 652 | 0.020 |
Why?
|
| Benzamides | 1 | 2013 | 1371 | 0.020 |
Why?
|
| Cancer Vaccines | 2 | 2005 | 1037 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 1987 | 224 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2008 | 767 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1989 | 908 | 0.020 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1987 | 490 | 0.020 |
Why?
|
| Genotype | 2 | 2016 | 12977 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2006 | 6403 | 0.020 |
Why?
|
| Echocardiography | 1 | 2019 | 4987 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2006 | 225 | 0.020 |
Why?
|
| Microcirculation | 1 | 2011 | 1272 | 0.020 |
Why?
|
| Candidiasis | 1 | 2009 | 365 | 0.020 |
Why?
|
| Culicidae | 1 | 2006 | 108 | 0.020 |
Why?
|
| Lymphoma | 1 | 1995 | 1899 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2006 | 294 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1333 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1998 | 2223 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2007 | 489 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2006 | 17878 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2006 | 364 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2017 | 1957 | 0.020 |
Why?
|
| Fucosyltransferases | 1 | 2005 | 117 | 0.020 |
Why?
|
| Thiophenes | 1 | 2010 | 569 | 0.020 |
Why?
|
| Fucose | 1 | 2005 | 122 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 6305 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 614 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2007 | 459 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1987 | 1738 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2013 | 2838 | 0.020 |
Why?
|
| Histocompatibility | 1 | 2005 | 317 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 2007 | 625 | 0.010 |
Why?
|
| Receptors, IgE | 1 | 2006 | 375 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2008 | 583 | 0.010 |
Why?
|
| Coronavirus Infections | 1 | 2002 | 3088 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2006 | 982 | 0.010 |
Why?
|
| Cardiovirus Infections | 1 | 2003 | 20 | 0.010 |
Why?
|
| Retroviridae | 1 | 2006 | 851 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 631 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2003 | 38 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1987 | 1540 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1988 | 1503 | 0.010 |
Why?
|
| Ion Channels | 1 | 2008 | 1039 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2010 | 1154 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2006 | 392 | 0.010 |
Why?
|
| Receptors, Purinergic P2Y | 1 | 2003 | 23 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2003 | 106 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 58919 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2019 | 8473 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2872 | 0.010 |
Why?
|
| Enterovirus Infections | 1 | 2003 | 74 | 0.010 |
Why?
|
| Mesenteric Arteries | 1 | 2003 | 178 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 4058 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 2003 | 351 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 2003 | 183 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 2896 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2002 | 110 | 0.010 |
Why?
|
| Peroxiredoxins | 1 | 2002 | 51 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 3085 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2008 | 974 | 0.010 |
Why?
|
| Gastritis | 1 | 2004 | 199 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 613 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 1718 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 9026 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 1988 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 871 | 0.010 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2002 | 85 | 0.010 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2002 | 52 | 0.010 |
Why?
|
| Luciferases | 1 | 2003 | 712 | 0.010 |
Why?
|
| Young Adult | 3 | 2015 | 59191 | 0.010 |
Why?
|
| Aged | 6 | 2016 | 169092 | 0.010 |
Why?
|
| Peroxides | 1 | 2002 | 74 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2001 | 329 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2002 | 241 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2005 | 1084 | 0.010 |
Why?
|
| Dimerization | 1 | 2003 | 890 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 2001 | 245 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 2004 | 603 | 0.010 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2010 | 918 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 1130 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 740 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2001 | 201 | 0.010 |
Why?
|
| Immune Sera | 1 | 2001 | 605 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1624 | 0.010 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2000 | 89 | 0.010 |
Why?
|
| Skull | 1 | 2005 | 818 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3776 | 0.010 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2000 | 49 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 4512 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 2002 | 711 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2011 | 5239 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 2001 | 211 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 2475 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 20556 | 0.010 |
Why?
|
| Europe | 1 | 2007 | 3415 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2001 | 225 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 4172 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2000 | 555 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2002 | 535 | 0.010 |
Why?
|
| Vaccines, DNA | 1 | 2001 | 283 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1697 | 0.010 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1999 | 52 | 0.010 |
Why?
|
| RNA Stability | 1 | 2001 | 320 | 0.010 |
Why?
|
| Oocytes | 1 | 1984 | 1166 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 1999 | 174 | 0.010 |
Why?
|
| Skin Tests | 1 | 2001 | 637 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 1812 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2001 | 1376 | 0.010 |
Why?
|
| Macrophage-1 Antigen | 1 | 1999 | 285 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2002 | 795 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 748 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4919 | 0.010 |
Why?
|
| Administration, Intravesical | 1 | 1998 | 91 | 0.010 |
Why?
|
| Bronchial Neoplasms | 1 | 1999 | 110 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 1989 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2001 | 629 | 0.010 |
Why?
|
| Medulloblastoma | 1 | 2003 | 677 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 673 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1998 | 212 | 0.010 |
Why?
|
| Chickens | 1 | 1999 | 858 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 5671 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1998 | 817 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1998 | 397 | 0.010 |
Why?
|
| Administration, Topical | 1 | 1999 | 703 | 0.010 |
Why?
|
| Lymphokines | 1 | 2000 | 925 | 0.010 |
Why?
|
| Leukemia | 1 | 2005 | 1520 | 0.010 |
Why?
|
| HIV Core Protein p24 | 1 | 1997 | 245 | 0.010 |
Why?
|
| Pancreas | 1 | 2003 | 1691 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2000 | 1525 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1997 | 304 | 0.010 |
Why?
|
| HLA-A2 Antigen | 1 | 1997 | 209 | 0.010 |
Why?
|
| Keratins | 2 | 1988 | 498 | 0.010 |
Why?
|
| Urologic Neoplasms | 1 | 2000 | 314 | 0.010 |
Why?
|
| Jejunum | 1 | 1998 | 472 | 0.010 |
Why?
|
| Chromatin | 1 | 1987 | 2955 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 26065 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1995 | 777 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2003 | 2929 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2003 | 2456 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 1999 | 1814 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1985 | 2478 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2004 | 2329 | 0.010 |
Why?
|
| United States | 2 | 2016 | 72292 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1999 | 2925 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1999 | 1202 | 0.010 |
Why?
|
| Hybridomas | 1 | 1994 | 442 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1987 | 3611 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2001 | 3392 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 8426 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 6861 | 0.010 |
Why?
|
| Adolescent | 2 | 2010 | 88247 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 3606 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14649 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1995 | 1226 | 0.010 |
Why?
|
| Transglutaminases | 1 | 1991 | 196 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1999 | 6339 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 5838 | 0.010 |
Why?
|
| Insulin | 1 | 2003 | 6593 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2003 | 3481 | 0.000 |
Why?
|
| Linear Models | 1 | 1998 | 5866 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 4947 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 15250 | 0.000 |
Why?
|
| Leishmaniasis | 1 | 1987 | 67 | 0.000 |
Why?
|
| Carcinoma | 1 | 1999 | 2328 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1999 | 9644 | 0.000 |
Why?
|
| Leprosy | 1 | 1987 | 126 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1999 | 12333 | 0.000 |
Why?
|
| Child | 1 | 2010 | 80089 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2004 | 41464 | 0.000 |
Why?
|
| Xenopus laevis | 1 | 1984 | 963 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 36401 | 0.000 |
Why?
|